Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
2
×
biotech
boston blog main
boston top stories
clinical trials
deals
2
×
life sciences
national blog main
national top stories
sanofi
alirocumab
alnylam pharmaceuticals
cancer
cancer drugs
cobimetinib
evolocumab
fda
inclisiran
investing
ipo
new york
new york blog main
new york top stories
novartis
pcsk9
pcsk9 inhibitors
regeneron pharmaceuticals
revolution medicines
rna interference
roche
san francisco
san francisco blog main
san francisco top stories
the column group
the medicines company
third rock ventures
university of illinois
venture capital
warp drive bio
What
drug
medicines
2
×
acquire
agreed
billion
brings
cancer
cash
cholesterol
company
compound
deal
despite
family
fda
hardest
hit
hottest
hunters
ipo
medco
new
novartis
poised
proteins
ras
ready
reels
research
revolution
targets
wave
Language
unset
Current search:
deals
×
medicines
×
amgen
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
